Melissa M. Wagner is a seasoned strategic business executive with extensive experience in business development within the biosciences and healthcare sectors. As a co-founder and owner of BlueLine32 Brew since December 2018, Wagner drives a home brewing company dedicated to producing quality beer. In a dual role at SRI International since May 2017, Wagner serves as the Strategic Business Executive and Global Head of Biosciences Commercial Partnerships, as well as Senior Director of Strategic Business Development, focusing on research and industry trends. Past roles include Regional Program Director at United Heroes League, Senior Director at hVIVO, and Executive Director positions at PPD Global Central Laboratory and Viracor-IBT Laboratories. Wagner has a solid educational foundation with a Bachelor's of Science in Business Administration from Century University, an MBA from Concordia University, and credentials as a Medical Technologist.